✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Intra-Cellular Therapies Inc

Common Name
Intra-Cellular Therapies
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
860
Ticker
ITCI
Exchange
NASDAQ/NGS
Description
Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat...

Disclosures of Intra-Cellular Therapies

Explore Intra-Cellular Therapies's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Intra-Cellular Therapies's official channels and fully traceable to its official company sources.

The table below lists all of Intra-Cellular Therapies's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20242 disclosures
10-K
en
10-K
en
20232 disclosures
10-K
en
Sustainability Report
en
20221 disclosure
10-K
20211 disclosure
10-K
20201 disclosure
10-K
20191 disclosure
10-K
20181 disclosure
10-K
20171 disclosure
10-K
20161 disclosure
10-K
20151 disclosure
10-K
20141 disclosure
10-K
20132 disclosures
10-K
10-K
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?